It’s not just doctors paying attention to Epocrates. App developers and VCs are also looking at the VC-backed, San Mateo, Calif.-based company, which develops mobile point-of-care solutions for health care professionals. Essentially, it provides a drug reference guide and other resources that docs can access on their mobile devices.
The company (Nasdaq:EPOC) went public on Feb. 2, raised about $86 million and saw its stock price raise 38% in its first day of trading.
It is estimated that more than 300,000 U.S. health care professionals now use Epocrates’ products, 45% of all practicing physicians, and 1 million worldwide.
Tom York, a contributor to Venture Capital Journal, explored the growing use of Epocrates and mobile apps for the health care field and reported on it for the April issue of VCJ. As a treat, subscribers can access the article now by clicking here.
In the article, Tom found that the large user base of Epocrates has other VCs taking note. And some are wondering if wireless health care could be the next big investment trend.
“The stars are beginning to align in favor of new companies” Bijan Salehizadeh, general partner at Highland Capital Partners, tells VCJ. “It is an extremely robust time for mobile health from a business perspective.”
Health care IT for mobile devices is one of the fastest growing categories in venture investing, Salehizadeh says.
Not a VCJ subscriber? Click here for a free trial.
And if you want to talk to us about mobile health care IT or other hot investment area, send an email to VCJ Editor-in-Charge Alastair Goldfisher at [email protected].